Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dana Litvak-Greenfeld"'
Autor:
Lilach Vaks, Dana Litvak-Greenfeld, Stav Dror, LeeRon Shefet-Carasso, Galia Matatov, Limor Nahary, Shiran Shapira, Rahely Hakim, Iris Alroy, Itai Benhar
Publikováno v:
Antibodies, Vol 7, Iss 3, p 27 (2018)
Bispecific antibodies (bsAbs) are antibodies with two binding sites directed at different antigens, enabling therapeutic strategies not achievable with conventional monoclonal antibodies (mAbs). Since bispecific antibodies are regarded as promising t
Externí odkaz:
https://doaj.org/article/b8e5a2a749c5447c9e18022c94bf9c22
Autor:
Assaf Shapira, Meital Gal-Tanamy, Limor Nahary, Dana Litvak-Greenfeld, Romy Zemel, Ran Tur-Kaspa, Itai Benhar
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e15916 (2011)
The synthesis of inactive enzyme precursors, also known as "zymogens," serves as a mechanism for regulating the execution of selected catalytic activities in a desirable time and/or site. Zymogens are usually activated by proteolytic cleavage. Many v
Externí odkaz:
https://doaj.org/article/52f1c18b1d9a4efdb713441d923e9515
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1904
Bispecific antibodies (bsAbs) are antibodies with two binding sites directed at different antigens, enabling therapeutic strategies not possible with conventional monoclonal antibodies (mAbs). Since bispecific antibodies are regarded as promising the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2bef99f972b77b65b6c9a9158cb9fb7f
https://pubmed.ncbi.nlm.nih.gov/30539485
https://pubmed.ncbi.nlm.nih.gov/30539485
Publikováno v:
Methods in Molecular Biology ISBN: 9781493989577
Bispecific antibodies (bsAbs) are antibodies with two binding sites directed at different antigens, enabling therapeutic strategies not possible with conventional monoclonal antibodies (mAbs). Since bispecific antibodies are regarded as promising the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c29ec16368e1740597e53fcf0396c02
https://doi.org/10.1007/978-1-4939-8958-4_22
https://doi.org/10.1007/978-1-4939-8958-4_22
Autor:
Stav Dror, Shiran Shapira, LeeRon Shefet-Carasso, Lilach Vaks, Limor Nahary, Itai Benhar, Rahely Hakim, Galia Matatov, Dana Litvak-Greenfeld, Iris Alroy
Publikováno v:
Antibodies
Volume 7
Issue 3
Antibodies, Vol 7, Iss 3, p 27 (2018)
Volume 7
Issue 3
Antibodies, Vol 7, Iss 3, p 27 (2018)
Bispecific antibodies (bsAbs) are antibodies with two binding sites directed at different antigens, enabling therapeutic strategies not achievable with conventional monoclonal antibodies (mAbs). Since bispecific antibodies are regarded as promising t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f74b09343c1bfdf6d5d59fe6376ffe
Autor:
Itai Benhar, Dana Litvak-Greenfeld
Publikováno v:
Advanced drug delivery reviews. 64(15)
Antibody-based immunoconjugates are specifically targeted monoclonal antibodies that deliver a cytotoxic payload to their target. The cytotoxic agents can be highly potent drugs, radionuclides or toxins. Such molecules, referred to as antibody–drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0fcb2385bda6aecb1de1ecb53ca202
https://pubmed.ncbi.nlm.nih.gov/22659123
https://pubmed.ncbi.nlm.nih.gov/22659123
Autor:
Romy Zemel, Dana Litvak-Greenfeld, Assaf Shapira, Itai Benhar, Ran Tur-Kaspa, Limor Nahary, Meital Gal-Tanamy
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 1, p e15916 (2011)
PLoS ONE, Vol 6, Iss 1, p e15916 (2011)
The synthesis of inactive enzyme precursors, also known as "zymogens," serves as a mechanism for regulating the execution of selected catalytic activities in a desirable time and/or site. Zymogens are usually activated by proteolytic cleavage. Many v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367812d04f2dc599c92fe112ad3852b7
https://doi.org/10.1371/journal.pone.0015916
https://doi.org/10.1371/journal.pone.0015916